Model: | Ratio |
Symbol | Title | Sector | Industry | M.Cap.[M] | Div Yield | Last Close | AvgVol 200d |
IDNA | iShares Genomics Immunology and Healthcare ETF | 0.0088 | 20.23 | 31355 | |||
XBI | SPDR® S&P Biotech ETF | 0 | 79.19 | 9452613 |
Entry Threshold: | 0.20 | Exit Threshold: | 0.00 | ||
Max Duration: | 20 | Entry Mode: | Simple | Reversals: | |
Inverted: | IDNA | Transformed: | IDNA | A=1000.0 B=0.1 | |
MA Period: | 15 | MA Type: | EMA | StdDev Period: | 15 |
RSI Period: | 6 | RSI Threshold: | 15 | ||
Margin Req. 1: | 50.0 | Margin Req. 2: | 50.0 | ||
Version: | 5 | Model Version: | 2016.1 | Bid-Ask 0.01 / 0.01 |
Initial Capital: | 10000.00 | Final Equity: | 2885.10 |
Total net P/L: | -7114.90 | Total ROI: | -71.15 % |
CAGR: | -20.81 % | Max. DD: | 82.61 % |
System Score: | -4.206 | Sharpe Ratio: | -0.227 |
Start Date: | 2020-01-02 | End Date: | 2025-04-30 |
Total days: | 1945 | ||
Commissions: | 503.78 | Comm.% P/L | 7.62 % |
Total Transactions: | 492 | Log. Linearity: | 58.688 % |
Total | ![]() |
![]() |
IDNA | XBI | |
---|---|---|---|---|---|
Total Profit/Loss | -6611.12 | -5503.37 | -1107.75 | -2859.57 | -3751.55 |
Total Profit | 20184.32 | 7241.77 | 12942.56 | 10342.65 | 10368.36 |
Total Loss | 26795.44 | 12745.13 | 14050.31 | 13202.22 | 14119.91 |
Profit Factor | 0.75 | 0.57 | 0.92 | 0.78 | 0.73 |
Trades | 123 | 55 | 68 | 123 | 123 |
Winning Trades | 83 | 36 | 47 | 84 | 82 |
Losing Trades | 40 | 19 | 21 | 38 | 41 |
% Profitable | 67.00 | 65.00 | 69.00 | 68.00 | 66.00 |
Profit/Loss Per Trade % | -0.90 | -1.69 | -0.26 | -0.19 | -0.35 |
Profit Per Trade % | 5.54 | 5.04 | 5.94 | 2.81 | 2.88 |
Loss Per Trade % | 11.74 | 11.77 | 11.71 | 6.24 | 6.14 |
Days In Trade | 1364 | 675 | 689 | 1364 | 1364 |
Days In Trade (Avg. Per Trade) | 11.09 | 12.27 | 10.13 | 11.09 | 11.09 |
% Days In Trade | 70.13 | 34.70 | 35.42 | 70.13 | 70.13 |